JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the 2025 Transcatheter Cardiovascular Therapeutics (TCT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback